Abstract:A bioactive biomimetic nanovesicle, co‐containing the natural adenosine deaminase and photothermal agent FeS, is innovatively designed and fabricated based on erythrocytes. The nanovesicle effectively reverses adenosine's immunosuppressive function, and in synergy with photothermal therapy, leads to a significant improvement in the immunogenic tumor microenvironment and enhances the therapeutic efficacy of photoimmunotherapy. Adenosine has garnered significant attention as a potential target for overcoming tumor immune evasion. It exacerbates the immunosuppressive tumor microenvironment (TME) by incapacitating various protective immune cells. However, inhibitors targeting adenosine receptors are limited by incomplete blockade effects and off‐target toxicity, necessitating the exploration of more effective strategies. Inspired by the native biologic function of adenosine deaminase (ADA) in hydrolyzing adenosine, a bioactive catalytic nanovesicle (ENV@FeS) is designed to reverse adenosine immunosuppressive function. The nanovesicle is constructed through the serial extrusion of erythrocytes abundant with ADA, coupled with the synthesis of FeS complex in situ using Fe2+ in erythrocytes via H2S gas introduction. Notably, the bioactive nanovesicles not only promote tumor targeting and induce immunogenic cell death by the FeS‐induced photothermal effect, but also hinder the adenosine pathway by metabolizing adenosine into immunopotentiator inosine, further boosting antitumor immunity. In vivo, ENV@FeS efficiently increases the infiltration of cytotoxic T lymphocytes and M1 macrophages while reducing the production of regulatory T cells and myeloid‐derived suppressor cells, resulting in significant inhibition of tumor growth. Together, the biomimetic nanovesicle‐mediated adenosine metabolic regulation, in synergy with photothermal therapy, leads to a marked improvement in the immunogenic TME and enhances the therapeutic efficacy of photoimmunotherapy.

Targeting the Negative Feedback of Adenosine‐A2AR Metabolic Pathway by a Tailored Nanoinhibitor for Photothermal Immunotherapy

Photothermal nanobomb blocking metabolic adenosine-A2AR potentiates infiltration and activity of T cells for robust antitumor immunotherapy

Erythrocyte‐Derived Bioactive Nanovesicles Reverse the Immunosuppressive Function of Adenosine for Tumor Photoimmunotherapy

Second Near‐Infrared Light‐Activatable Polymeric Nanoantagonist for Photothermal Immunometabolic Cancer Therapy

Reversing the negative effect of adenosine A1 receptor-targeted immunometabolism modulation on melanoma by a co-delivery nanomedicine for self-activation of anti-PD-L1 DNAzyme

Dynamic Adjust of Non‐Radiative and Radiative Attenuation of AIE Molecules Reinforces NIR‐II Imaging Mediated Photothermal Therapy and Immunotherapy

Potentiating dual-directional immunometabolic regulation with nanomedicine to enhance anti-tumor immunotherapy following incomplete photothermal ablation

A macrophage membrane-coated mesoporous silica nanoplatform inhibiting adenosine A2AR via in situ oxygen supply for immunotherapy

The potential of nanosystems in disrupting adenosine signaling pathways for tumor immunotherapy

PD-L1 Targeting Nanotheranostic for Effective Photoacoustic Imaging Guided Photothermal-Immunotherapy of Tumor

Design, Synthesis, and Bioevaluation of 2-Aminopteridin-7(8h)-one Derivatives As Novel Potent Adenosine A2A Receptor Antagonists for Cancer Immunotherapy

ATP-exhausted nanocomplexes for intratumoral metabolic intervention and photoimmunotherapy

2D Antimonene-Integrated Composite Nanomedicine for Augmented Low-Temperature Photonic Tumor Hyperthermia by Reversing Cell Thermoresistance.

Integration of gold nanodendrites and immune checkpoint blockers to achieve highly efficient photothermal immunotherapy for eradicating primary and distant metastatic osteosarcoma

Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function

Activatable polymer nanoagonist for second near-infrared photothermal immunotherapy of cancer

In situ thermal ablation of tumors in combination with nano-adjuvant and immune checkpoint blockade to inhibit cancer metastasis and recurrence.

Biomimetic nanoparticles for effective mild temperature photothermal therapy and multimodal imaging

ATP-adenosine axis regulation combined with microneedle assisted photoimmunotherapy to boost the immunotherapy efficiency

T Cell Membrane Mimicking Nanoparticles with Bioorthogonal Targeting and Immune Recognition for Enhanced Photothermal Therapy

Self-Delivery Nanomedicines Reverse Thermal Resistance to Enhance Tumor Mild-Temperature Photothermal Therapy